This inventor holds 1 USPTO granted patent. Top assignee: Ucl Business Plc. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Anne Kramer: Innovator in Chimeric Antigen Receptor Technology
Introduction
Anne Kramer is a notable inventor recognized for her contributions to the field of biotechnology. She has developed innovative solutions that have the potential to impact cancer treatment significantly. Her work focuses on the development of chimeric antigen receptors, which are crucial in targeted therapies.
Latest Patents
Anne Kramer holds a patent for a Chimeric Antigen Receptor (CAR) comprising a CD19-binding domain. This invention represents a significant advancement in the treatment of diseases, particularly in the realm of immunotherapy.
Career Highlights
Anne Kramer is currently associated with UCL Business Plc, where she continues to work on groundbreaking research and development projects. Her expertise in the field has positioned her as a key player in the biotechnology sector.
Collaborations
Anne collaborates with Leila Mekkaoui, who is also a talented professional in the field. Together, they contribute to innovative research that aims to enhance therapeutic options for patients.
Conclusion
Anne Kramer's work exemplifies the spirit of innovation in biotechnology, particularly through her patent on chimeric antigen receptors. Her contributions are paving the way for future advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile